undamentalytics Newsletter
Sign in

Insmed Inc cash flow statement

In fiscal 2025, Insmed Inc's operations generated −$935m of cash; it spent $32.6m on capital projects, leaving free cash flow of −$968m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations−11−8−30−31−47−101−147−160−258−251−219−363−400−536−684−935−596
Depreciation and amortisation1001122345995661013
Stock-based pay3023916181826273646587597153167
Capital spending001013431342671013223332
Free cash flow−11−8−31−31−47−104−151−163−271−293−226−371−410−550−706−968−628
Free cash flow after stock pay−14−8−33−34−56−120−169−181−297−320−262−417−468−624−803−1,120−795
Shares issued1002667223037802612462702921521,084823—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: HALO vs INSMALKS vs INSMINSM vs MDGL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Insmed Inc's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Insmed Inc.